Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans
出版年份 2020 全文链接
标题
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans
作者
关键词
-
出版物
JCI Insight
Volume 5, Issue 24, Pages -
出版商
American Society for Clinical Investigation
发表日期
2020-11-11
DOI
10.1172/jci.insight.144079
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
- (2020) Stefano Romeo et al. Cell Metabolism
- NAFLD 2020: The State of the Disease
- (2020) Thomas G. Cotter et al. GASTROENTEROLOGY
- Causes and Consequences of Hypertriglyceridemia
- (2020) Chris J. Packard et al. Frontiers in Endocrinology
- Disruption of the ERLIN–TM6SF2–APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease
- (2020) Bo-Tao Li et al. PLoS Genetics
- Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
- (2019) Martijn C. G. J. Brouwers et al. DIABETOLOGIA
- The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids
- (2019) Sebastian Prill et al. Scientific Reports
- Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
- (2018) Juan Pablo Arab et al. Annual Review of Pathology-Mechanisms of Disease
- TM6SF2: A novel target for plasma lipid regulation
- (2018) Ting-Ting Li et al. ATHEROSCLEROSIS
- Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
- (2018) Varman T. Samuel et al. Cell Metabolism
- Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
- (2018) David Højland Ipsen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis
- (2017) Nicole Ehrhardt et al. HUMAN MOLECULAR GENETICS
- Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD
- (2017) Panu K. Luukkonen et al. JOURNAL OF HEPATOLOGY
- Lipid droplets and liver disease: from basic biology to clinical implications
- (2017) Nina L. Gluchowski et al. Nature Reviews Gastroenterology & Hepatology
- Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions
- (2017) Meenakshi Sundaram et al. JOURNAL OF LIPID RESEARCH
- Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes
- (2016) Mohammed Eslam et al. HEPATOLOGY
- Inactivation ofTm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins
- (2016) Eriks Smagris et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal ObesitySignificance
- (2015) Jan Borén et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
- (2015) Paola Dongiovanni et al. HEPATOLOGY
- Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2
- (2015) You Zhou et al. JOURNAL OF HEPATOLOGY
- Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk
- (2014) Oddgeir L Holmen et al. NATURE GENETICS
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
- (2014) Julia Kozlitina et al. NATURE GENETICS
- Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins
- (2014) Niina Matikainen et al. Obesity
- TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content
- (2014) H. Mahdessian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ectopic lipid storage and insulin resistance: a harmful relationship
- (2013) J. Borén et al. JOURNAL OF INTERNAL MEDICINE
- Genetic Variation in SULF2 Is Associated with Postprandial Clearance of Triglyceride-Rich Remnant Particles and Triglyceride Levels in Healthy Subjects
- (2013) Niina Matikainen et al. PLoS One
- Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia
- (2012) Janet D. Sparks et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Skeletal Muscle Insulin Resistance Promotes Increased Hepatic De Novo Lipogenesis, Hyperlipidemia, and Hepatic Steatosis in the Elderly
- (2012) C. Flannery et al. DIABETES
- Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
- (2012) Carlo Pirazzi et al. JOURNAL OF HEPATOLOGY
- The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma
- (2012) Lars Löfgren et al. JOURNAL OF LIPID RESEARCH
- Phosphatidylcholine Synthesis for Lipid Droplet Expansion Is Mediated by Localized Activation of CTP:Phosphocholine Cytidylyltransferase
- (2011) Natalie Krahmer et al. Cell Metabolism
- Long-TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat
- (2010) Jesper Lundbom et al. NMR IN BIOMEDICINE
- Lipid droplets as dynamic organelles connecting storage and efflux of lipids
- (2008) Sven-Olof Olofsson et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now